It's a superficial red flag for those who don't look. PFE isn't interested in BC that much, and it has a similar candidate in more advanced stage development for different types of cancer. PFE has narrowed their oncology focus significantly.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.